Abstract-We compared amphetamine-induced dopamine release in the nucleus accumbens of vole species that exhibit differing mating systems to examine potential interactions between social organization and substance abuse. We found no species or regional differences in basal extracellular dopamine, however, monogamous voles had greater and longer-lasting increases in extracellular dopamine after amphetamine treatment than did promiscuous voles. We then examined whether amphetamine-induced increase in extracellular dopamine could induce pair bonds in monogamous voles. We found that, despite increasing dopamine in the nucleus accumbens, amphetamine administration did not induce pair-bonds in male prairie voles unless the animals were pretreated to preclude D1 receptor activation, which is known to inhibit pair-bond formation. These results support suggestions that social attachment and substance abuse share a common neural substrate.
The genus Microtus (voles) is an ideal group of animals in which to study the processes underlying pair-bonding between adults. Although quite similar in many ways, the different vole species display a variety of mating systems ranging from promiscuity to monogamy (Dewsbury, 1981; Shapiro and Dewsbury, 1990; Cushing et al., 2001) . For example, meadow (Microtus pennsylvanicus) and montane (M. montanus) voles display promiscuous mating systems and only females provide parental care. In these species, males and females occupy separate nests, defend different territories, and do not form pair-bonds between mates (Shapiro and Dewsbury, 1990; Insel et al., 1995) . In contrast, prairie (M. ochrogaster) and pine (M. pinetorum) voles form long-term, monogamous pairbonds. In these species, both males and females provide parental care, and both sexes share a nest and vigorously defend common territory against unfamiliar conspecifics (Getz et al., 1981; Hofmann et al., 1984; Gruder-Adams and Getz, 1985) .
Evidence accumulated over the past several years has firmly established a role for central dopamine systems, especially the mesocorticolimbic "reward" pathways, in the formation and maintenance of monogamous pair-bonds. The results to date suggest that, during pair-bond formation, decreased excitatory activity in the ventral tegmental area (VTA) causes increased dopamine release in the nucleus accumbens (NAcc) (Gingrich et al., 2000; Curtis and Wang, 2005) . Within the anterior shell portion of NAcc (but not in the posterior shell or the core), dopamine activates D2-type receptors to induce the partner preference behavior associated with pair-bonds (Gingrich et al., 2000; Aragona et al., 2003 Aragona et al., , 2006 . In contrast, for individuals that already are pair-bonded, activation of D1-type dopamine receptors produces antagonistic behavior toward conspecific strangers that may serve to inhibit the formation of a second pair-bond .
The mesocorticolimbic dopamine system also plays a pivotal role in drug addiction (Self et al., 1998; Yun et al., 2004) , and a number of authors have suggested that addictive substances "hijack" the central processes that normally mediate social attachment (Lende and Smith, 2002; Panksepp et al., 2002; Insel, 2003) . Such a suggestion is supported by observations that social isolation is a potent stimulus for self-administration of addictive substances (Howes et al., 2000) . Although few studies have directly tested potential interactions between social bonding and substance abuse, many of the processes that mediate pair-bond formation appear to have functional analogues among the processes that mediate substance abuse. For example, a number of addictive substances alter excitatory inputs and/or responses in the VTA (Kalivas and Duffy, 1998; Saal et al., 2003) . Further, drugs such as amphetamine produce significant increases in extracellular dopamine within the NAcc (Zocchi et al., 2003) and there often are rostral/caudal and/or core/shell differences in such responses (Heidbreder and Feldon, 1998; Di Chiara, 2002) . Finally, D1-and D2-type dopamine receptors can produce opposing effects on drug-seeking behavior; D2 activation initiates drug seeking while D1 activation reduces drug-seeking (Self et al., 1996) .
Since both pair-bonding and substance abuse involve the same systems, and since both processes may involve changes in neurotransmission (Saal et al., 2003; Aragona et al., 2006) , it is conceivable that the two processes may exert reciprocal effects. Consistent with this possibility, strong social ties may reduce substance abuse (Recio Adrados, 1995; Ellickson et al., 1999; Bell et al., 2000) or may aid in recovery from previous substance abuse (Havassy et al., 1995) . Furthermore, there are indications that substance abuse may negatively impact pair-bonding in humans. For example, substance abuse has been found to affect patterns of marriage and divorce (Yamaguchi and Kandel, 1985; Kandel et al., 1994; Kaestner, 1995) . Unfortunately, relatively little is known about the mechanisms by which such effects may be exerted. In the present study, we used a comparative approach to examine potential species differences in responses to amphetamine administration that may be correlated with species-typical mating systems in vole species that either form or do not form pair bonds. We then tested whether amphetamine-stimulated dopamine overflow could induce pair-bonds in monogamous voles.
EXPERIMENTAL PROCEDURES Subjects
Sexually naïve adult prairie and meadow voles were used to assess the effects of amphetamine treatment on extracellular levels of dopamine and the dopamine metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the NAcc. Subjects were captive bred males descended from populations from southern Illinois. Colonies were periodically outcrossed to maintain genetic variability. Pups were weaned at ϳ21 days of age and housed in same sex pairs in plastic shoebox style cages (20ϫ50ϫ40 cm) with a 14L:10D photoperiod and ad libitum food (Purina rabbit chow (Purina Mills, St. Louis, MO, USA) supplemented with black oil sunflower seeds) and water. Animals were transferred to clean cages weekly. The species and sexes were housed separately. All procedures were approved by the Florida State University Institutional Animal Care and Use Committee and were in accordance with the U.S. National Institutes of Health Guide for the Care and Use of Laboratory Animals. Every effort was made to minimize the number of animals needed and their suffering to carry out the experiments.
Microdialysis probe construction and implantation
Microdialysis probes were constructed as previously described except the active area was 1.5 mm and the molecular weight cutoff of the membrane was 18 kDa. Probes with this design have a dopamine recovery of 5-7%. Probes were implanted stereotaxically into the left NAcc (coordinates from bregma: anterior 2.1 mm, lateral 0.6 mm, ventral 6.3 mm) under sodium pentobarbital anesthesia (1 mg/10 kg bodyweight) and animals were allowed to recover overnight. Probes were perfused continuously at 2.3 l/min with a solution isotonic for sodium, potassium, calcium, and magnesium (144 mM NaCl, 2.8 mM KCl, 1.2 mM CaCl 2 , and 0.9 mM MgCl 2 (Sved and Curtis, 1993) ).
Sample collection and dialysate analysis
Dialysate samples were collected into vials containing 5 l of 0.1 N perchloric acid and immediately frozen at Ϫ80°C until analyzed. Dialysate levels of dopamine, DOPAC, and HVA were determined using high performance liquid chromatography (HPLC) with electrochemical detection (ECD, ESA, Inc., Chelmsford, MA, USA). For each sample, 45 l of dialysate was injected on column. Analytes were separated using an Alliance Separations Module (Waters, Inc., Milford, MA, USA), and an MD-150 column (ESA, Inc.) with a mobile phase (flow rate 0.7 l/min) consisting of 75 mM sodium dihydrogen phosphate monohydrate (EM Science, Washington, PA, USA), 1.7 mM 1-octanesulfonic acid sodium salt (Sigma, St. Louis, MO, USA), 0.01% triethylamine (Aldrich, USA), 25 M EDTA (Fisher, Pittsburgh, PA, USA), pH adjusted to 3.0 with ϳ 2 ml/l of 85% phosphoric acid (Fisher). Analyte detection was achieved by first oxidizing the samples at 400 mV, followed by reduction at Ϫ350 mV. DOPAC and HVA were quantified using oxidation peaks at low gain, while dopamine was quantified using reduction peaks at high gain. Peak areas were converted to amounts (pg analyte/45 l, not corrected for probe recovery) by comparisons with peaks produced using standards of known concentration. The quantification limit for dopamine was ϳ2 pg/45 l injection, and the detection limit was ϳ0.5 pg/45 l injection.
Acute effects of peripheral amphetamine treatment
Following overnight recovery, four 20-minute baseline samples were collected, after which each male received an i.p. injection either of 200 l/40 g body weight of saline or of saline containing 3 mg/kg amphetamine. Samples then were collected at 20-minute intervals for 3 h and analyzed using HPLC-ECD.
Effects of amphetamine within NAcc
Two additional groups of males of each species were used to examine the effects of amphetamine administered directly into the NAcc via reverse microdialysis while collecting samples for dopamine analysis. In the first group, after baseline sampling, the dialysis fluid was switched to one containing 1 mM amphetamine for three 20-minute sampling periods followed by return to standard dialysis fluid for another 2 h. This experiment was designed to assess maximally stimulated short-term responses to amphetamine treatment. In the second group, after baseline sampling, the dialysis fluid was replaced with one containing 100 M amphetamine. Thereafter, amphetamine levels were ramped up by increasing the concentration after every second sample. Amphetamine concentrations tested were 0, 100, 200, 400, and 800 M and 1 mM. Since it required approximately 12 min for a new concentration of amphetamine to reach the active area of the probe following changes between solutions, the first sample at each concentration was a transitional sample, while the target concentration of amphetamine was present for 3 min prior to, and then throughout, the second sampling period at each concentration. This experiment was designed to test longer-term sustained responses to amphetamine treatment.
Assessment of microdialysis probe placement
At the end of the microdialysis sampling period, animals were given an overdose of sodium pentobarbital and the brains were removed for assessment of probe placements. Brains were sectioned at 40 m on a cryostat and sections through the NAcc were thaw-mounted onto microscope slides. Probe placement was assessed in freshly mounted tissue, or in some cases, in Nisslstained tissue. Determination of placement was made using the regional delineations described by Paxinos and Watson (1998) . The genu of the corpus callosum was used to delineate anterior from posterior placement within the NAcc. Probes with tracks medial to the lateral ventricle were considered to be in the NAcc shell, while those with tracks lateral to the ventricle were considered to be in the NAcc core. For inclusion in the study, at least 80% of the active area had to be within either the core or shell. Animals with probes that spanned significant portions of more than one region were excluded.
Effects of amphetamine treatment on partner preference formation
In the first experiment, male prairie voles (nϭ7-10/group) received i.p. injections of 200 l/40 g body weight of saline or of saline containing 0.5, 1.0, or 3.0 mg/kg of amphetamine. Each male then was paired with a sexually non-receptive, ovariecto-mized female of similar size and age for 6 h of non-sexual cohabitation. Interactions between members of each pair were videotaped for subsequent verification that mating did not occur during cohabitation and to assess potential behavioral deficits caused by drug treatment.
Immediately following the 6-h cohabitation period, each male was tested for a partner preference (Williams et al., 1992) . The apparatus for the partner preference test consisted of a neutral cage (20ϫ50ϫ40 cm) connected by tubes to two identical cages, one of which contained the familiar female partner while the other contained an unfamiliar female with which the male had never interacted. Females were tethered in their respective cages and thus had no contact with each other, while the male subject had unfettered access to all three cages. A customized computer program (R. Henderson, Florida State University) using a series of light-beams across the connecting tubes monitored the movement of the male among the cages. Testing lasted for 3 h. Again, the animals were videotaped for detailed behavioral analysis. Variables assessed included the time spent in close contact with each stimulus female as a measure of affiliative behavior, the amount of time spent in the neutral cage as a measure of general non-social behavior, and the number of crossings between cages as a measure of overall activity.
In the second experiment, male prairie voles were injected (i.p.) with 100 g/kg of SCH23390, a D1-type dopamine receptor antagonist. Thirty minutes later each male received either vehicle or 1 mg/kg amphetamine (i.p.), was paired with a female for 6 h, and then tested for a partner preference as described above.
Data analysis
Absolute amounts of dialysate dopamine were used for species, regional, and between treatment-groups comparisons of baseline amounts by analysis of variance (ANOVA) (Statistica). For these comparisons, the mean of the four baseline samples for each animal was used. Detailed descriptions of the various combinations of factors used in the ANOVAs are presented with the results. Species comparisons for basal DOPAC and HVA were made using independent t-tests.
For all other comparisons, the amounts of dopamine or its metabolites in each baseline and post-amphetamine sample were expressed as a percentage of the mean baseline amount. These values then were used in repeated measures ANOVAs with change in analyte amount across time as the repeated measure. In a small number of cases, it was necessary to estimate values for missing samples to use repeated measures analyses. In these cases, the mean of all samples for the appropriate time period was calculated. Median interpolation then was used to generate a second estimate of the missing value. The mean of these two values then was used to replace the missing sample value. No animal included in the analyses had more than one sample value generated in this way. Student-Neuman-Keuls (SNK) post hoc analyses were used to further examine significant main effects or interactions (PϽ0.05). Again, descriptions of the various factors used in the ANOVAs are presented with the results. For a sample to be considered significantly different from baseline, that sample had to be significantly different from at least three of the four baseline samples as assessed by SNK post hoc analysis. Treatment effects on partner preferences were assessed using paired t-tests to compare the group means for amount of time spent in close contact with the partner vs. with the stranger. Examinations of other behaviors during the partner preference test were made using ANOVAs followed by SNK post hoc analyses when significant main effects or interactions were found.
RESULTS
All animals were at least 66 days old and thus sexually mature at the time of the experiments. The mean ages of animals did not differ either between species (F 1,49 ϭ0.17, Pϭ0.68) or treatment groups (F 4,49 ϭ0.01, Pϭ0.94).
Species, region, and sub-nucleus comparisons of basal dopamine levels
A three-way ANOVA was used to compare baseline dopamine levels. A total of 48 animals met the probe placement criteria (Fig. 1) 
Species comparisons after peripheral amphetamine administration
Male meadow and prairie voles received either of 200 l/40 g body weight of saline vehicle i.p. (nϭ5 for each species) or of saline containing 3 mg/kg of amphetamine (nϭ8 meadow voles, six prairie voles). Two-way ANOVA using species and treatment as factors revealed no differences in baseline dopamine levels (Table 2) either between species (F 1,23 ϭ1.29, Pϭ0.27) or between treatment groups (F 1,23 ϭ0.97, Pϭ0.33), although there was a significant interaction (F 1,23 ϭ5.11, Pϭ0.04). Post hoc assessment of the interaction revealed no significant pair-wise differences within species or between treatment groups although there was a marginal difference between the amphetamine and saline groups for meadow voles (Pϭ0.08).
Peripheral administration of 3 mg/kg amphetamine increased extracellular dopamine levels in the NAcc in both species (F 1,15 ϭ7.27, PϽ0.02); however, the magnitude and duration of the increase differed (species comparison F 1,15 ϭ17.10, PϽ0.01; species by time interaction F 12,180 ϭ2.24, PϽ0.02) between species (Fig. 2) . In prairie voles, amphetamine increased extracellular dopamine to about 275% of baseline, and although there was a gradual decline, dopamine levels remained significantly above baseline for at least five 20-minute sampling periods. In contrast, amphetamine increased extracellular dopamine only to about 175% of baseline in meadow voles, and levels were significantly elevated over baseline only for 40 min. Dopamine levels were unchanged after saline treatment in both species. The pattern was seen for absolute amounts of dopamine as well as for percent change from baseline. When the absolute amounts of dopamine recovered in each sample were compared between prairie and meadow voles that received amphetamine treatment, there was a significant species effect (F 13,117 ϭ8.09, PϽ0.001). Comparing individual time points, there were no species differences between any of the baseline values, but prairie voles displayed greater absolute amounts of extracellular dopamine (30.5Ϯ9.8 pg/sample) after amphetamine administration than did meadow voles (18.7Ϯ4.2 pg/sample).
Species comparisons for site-specific amphetamine administration
Site-specific administration of 1 mM amphetamine into the NAcc via reverse microdialysis significantly increased extracellular dopamine levels to approximately 2000% of baseline in both species (nϭ3 meadow voles and six prairie voles; Fig. 3A) . Further, the magnitudes and durations of the responses were similar in both species. Similarly, no species differences were found when the amphetamine concentration was slowly increased over several hours (nϭ4 meadow voles and 4 prairie voles; Fig. 3B ). In this experiment, reverse dialysis of 100 M amphetamine increased extracellular dopamine to about 700% of baseline. That level of do- Fig. 1 . Microdialysis probe placements. Each vertical black bar represents the active area of a single microdialysis probe based on postmortem probe placement assessments. Although all probes were placed in the left NAcc, for presentation purposes, shell placements (left hemisphere) and core placements (right hemisphere) are combined at each rostral-caudal level. Schematic brain sections were redrawn from Paxinos and Watson (1998) . Values are pg/45l of dialysate (meanϮS.E.M.); numbers of animals in each group are shown in parentheses. P-values are given for the main effects from a three-way ANOVA comparing species, anterior/posterior level, and core/shell comparisons. pamine release was sustained, but did not increase further despite an eventual 10-fold increase in the amphetamine concentration. There were no differences in basal extracellular dopamine either between experimental groups (F 1,13 ϭ0.001, Pϭ0.97) or between species (F 1,13 ϭ0.001, Pϭ0.98).
Amphetamine effects on dopamine metabolites in NAcc
Overall there were no species differences in baseline levels of either DOPAC (prairie 1159.7Ϯ295.9, meadow 1011. 2Ϯ171.4; tϭ0.56, Pϭ0.58) (Fig. 4A) . As with dopamine, the magnitude of the response was smaller and the duration shorter in meadow voles compared with that for prairie voles. Sitespecific administration of 1 mM amphetamine into NAcc via reverse dialysis significantly decreased extracellular DOPAC levels (F 12,132 ϭ23.06, PϽ0.001) in both species (Fig. 4B) . Levels remained depressed throughout the course of the test despite the fact that the amphetamine solution was replaced with normal dialysis fluid after only three samples. Ramped increases of amphetamine into the NAcc produced a similar pattern of decrease in extracellular DOPAC levels (F 12,48 ϭ15.70, PϽ0.001); however, this administration protocol produced a significant effect of species (F 1,4 ϭ17.18, PϽ0.02) and a species by treatment interaction (F 12, 48 ϭ2.24, PϽ0.03) . Although both groups displayed a decrease in extracellular DOPAC, the effect was more robust in meadow voles (Fig. 4C) . Extracellular levels of HVA were unaffected by either peripheral or site-specific administration in both species (all P-values Ͼ0.20, data not shown).
Amphetamine effects on pair-bonding
As expected, saline-treated males exposed to an ovariectomized female for 6 h of non-sexual contact displayed non-selective affiliation (Fig. 5A ) when subsequently given a choice between the familiar female and an unfamiliar ovariectomized female (tϭ0.69, Pϭ0.51). Amphetamine treatment at any of the three doses also failed to induce a partner preference (0.5 mg/kg: tϭ0.71, Pϭ0.50; 1.0 mg/kg: tϭ1. 26, Pϭ0.29; 3 mg/kg: tϭ0.05, Pϭ0.96) . However, when 1 mg/kg of amphetamine was administered after Fig. 2 . Peripheral administration of amphetamine increased extracellular dopamine within the NAcc. This response was greater in monogamous prairie voles (filled circles) than in promiscuous meadow voles (filled squares). Saline injections had no effect in either species (open symbols). Arrow indicates time of injection. * Significant difference from the within-species baseline.
# Sample periods for which there are significant species differences. pre-treatment with the D1-type dopamine receptor antagonist SCH23390 (Fig. 5B ), males displayed a preference for contact with the partner (tϭ2.46, PϽ0.05). Animals given SCH23390 followed by a saline injection displayed non-selective affiliative behavior similar to that seen for other control males (tϭϪ0.43, Pϭ0.68). There were no apparent behavioral deficits associated with any of the treatments (Table 3) . Specifically, total time spent in close contact with the two females did not differ between groups (F 5,46 ϭ0.46, Pϭ0.80). Non-social behaviors such as time spent in the neutral cage (F 5, 46 ϭ0.25, Pϭ0.94 ) and locomotor activity (F 5,46 ϭ1.46, Pϭ0.23) also were unaffected by treatment.
DISCUSSION
Comparative studies using voles have identified neuroanatomical and neurochemical differences that are well-correlated with species-specific mating systems (Insel and Shapiro, 1992; Wang, 1995; Lim et al., 2005) . Further, several studies have shown that pair-bonding involves re-organization of some brain regions (Bamshad et al., 1993; Wang et al., 1994) , most notably in portions of the mesolimbic dopamine pathway . Since some of the same areas that mediate pair bonding also are important in substance abuse, we examined whether the species differences that produce the various mating systems among voles also produce species-specific responses to drugs of abuse.
Species differences in NAcc dopamine response to amphetamine
Male prairie voles had a more robust and longer-lasting increase in extracellular dopamine in the NAcc after peripheral amphetamine administration than did meadow voles. This observation suggests that monogamous voles may be more sensitive to the effects of amphetamine than are promiscuous species. Thus, in monogamous species, the positive reinforcement effects of drugs such as amphetamine may be more robust than those experienced by promiscuous species. Alternatively, the species differences in drug-induced dopamine release could indicate that an amphetamine dose that is reinforcing for promiscuous voles could produce such an intense response in monogamous voles as to be aversive (Orsini et al., 2004) . In either case, changes in central pathways associated with substance abuse could be magnified in monogamous species.
We found no regional differences in basal extracellular dopamine levels in prairie and meadow voles, nor did we see any species differences when amphetamine was administered directly into the NAcc. These results provide further evidence that species differences in vole mating systems likely do not result from fundamental differences in dopamine neurocircuitry . Rather, the species differences likely arise from subtle differences in dopamine release or clearance, in the distribution or density of dopamine receptors, or in dopamine interactions with other neurotransmitter systems Lim and Young, 2004) . Since amphetamine targets the dopamine transporter (Jones et al., 1998) , the lack of species differences in stimulated levels in response to site-specific amphetamine administration suggests that the species do not differ in the density or function of dopamine transporters. Superficially, the lack of species differences in response to sustained amphetamine administration also suggests that the species do not differ in their capacities to produce dopamine. However, the species difference in extracellular DOPAC after sustained amphetamine treatment might argue against such an interpretation (Jones et al., 1998) . As with dopamine, the effects of amphetamine on extracellular DOPAC were greater and of longer duration in prairie voles than in meadow voles after peripheral administration, but when amphetamine was administered directly into NAcc, there was a greater DOPAC decrease in meadow voles. Given the lack of species differences in No species differences were noted; * significant increase over baseline for both species. The first sample at each concentration includes the transition between concentrations. Ordinate scale is the same in both panels to facilitate comparison of the responses to 1 mM amphetamine under each administration protocol. Fig. 4 . Amphetamine effects on extracellular levels of DOPAC. Peripheral administration of 3 mg/kg amphetamine significantly reduced NAcc DOPAC in both species, although the effect was greater in prairie voles (A). The effects of site specific administration of amphetamine via reverse dialysis within NAcc on extracellular DOPAC depended on the administration protocol. No species differences were found after a concentrated amphetamine dose (B), while a ramped administration paradigm produced greater effects in meadow voles (C). * Significant difference from the within species baseline. # Sample periods for which there are significant species differences. extracellular dopamine after amphetamine treatment in the same animals, it is unclear how to interpret these results. One possibility is that the greater reduction in extracellular DOPAC after site-specific amphetamine administration in meadow voles may reflect lower levels of intracellular dopamine in promiscuous voles. It must be noted that we cannot rule out the possibility that the species differences seen after peripheral amphetamine administration may simply reflect species differences in the ability to metabolize amphetamine.
Amphetamine and pair-bonding
The second major finding in the present study was that amphetamine treatment did not induce partner preferences in the absence of D1 dopamine receptor blockade. On the surface, this is an unexpected result. Increases in extracellular dopamine in NAcc are correlated with pairbond formation (Gingrich et al., 2000) , and short-term activation of the mesolimbic pathway is sufficient to induce partner preferences (Gingrich et al., 2000; Aragona et al., 2003 Aragona et al., , 2006 Curtis and Wang, 2005) . Since the microdialysis results show that amphetamine treatment increases dopamine release in prairie voles, a priori one might predict that amphetamine treatment would induce pair-bonds. Why then did amphetamine fail to induce partner preferences?
The answer may lie in the relative roles that activation of D1-and D2-type dopamine receptors play in pair bonding (Aragona et al., 2003) . Early studies of dopamine involvement in pair-bonding suggested that, while activation of D2 receptors facilitated pair-bond formation, D1 receptors were not involved in this process (Wang et al., 1999) . Subsequent work, however, has shown that activation of D1-type dopamine receptors actually prevents the formation of partner preferences induced either by pharmacological activation of D2 receptors or by mating . This opposing modulation is exemplified by the fact that the dopamine receptor agonist apomorphine induces pair-bonds in a dose-dependent fashion . At low concentrations apomorphine binds primarily to D2 receptors, facilitating pair-bonding. However, at higher concentrations, apomorphine binds to D1 receptors as well, negating the effects of D2 activation. A similar result would be expected for drugs such as amphetamine that produce essentially global increases in extracellular dopamine (Becker, 1990; Young and Rees, 1998; Yurek et al., 1998) . Such an increase is unlikely to produce preferential activation of only a specific subset of dopamine receptors, but rather would elicit non-specific activation of all dopamine receptors. Since concurrent activation of D1 and D2 receptors is inimical to pair-bonding , amphetamine-induced dopamine release does not induce partner preferences in the absence of D1 blockade. However, prior treatment with a D1 antagonist results in primarily D2 activation after amphetamine, and thus . Amphetamine-induced increases in NAcc dopamine did not induce partner preferences in male prairie voles unless animals were pre-treated to preclude D1-type dopamine receptor activation. At all doses of amphetamine tested, the amounts of time spent in close contact with the familiar partner and with the stranger were equivalent (A). In contrast, when males were pretreated with a D1 receptor antagonist, 1 mg/kg of amphetamine induced a significant preference for contact with the familiar partner (B). * Significantly more time spent in contact with the familiar partner. partner preferences are expressed after concurrent treatment with both drugs. These results also help to elaborate the role of D1 receptors in pair-bonding. Although there is good evidence that D1 activation inhibits pair bond formation and plays an important role in rejecting potential new mates Curtis et al., 2006) , previously, it was unknown whether blockade of D1 receptors alone was sufficient to induce pair-bonds. In the present study, D1 blockade alone did not induce partner preference formation. Thus, in the absence of D2 activation, simply reducing D1 activation is not sufficient for pair-bonding to occur.
It should be noted that the effects of D1 blockade did not result from behavioral suppression during the choice test. In one study, the dose of D1 antagonist used here produced some short-term motor impairment (Weatherford et al., 1990) . However, we found no apparent motor deficits; treated males did not differ from control males in non-social behaviors during the partner preference test. This may reflect differences in the timing of tests. In the present study there were at least 30 min between drug injection and the beginning of behavioral interactions and the critical dependent variable was not assessed until 6 -9 h after drug treatment. Thus, the increase in time spent with the familiar partner was not the result of changes in overall social contact, locomotor activity, or time spent in isolation. Rather, the difference in affiliative behavior was driven by a switch from non-selective affiliation to a preference for contact with the partner. It also is possible that D1 blockade altered behavior during the initial cohabitation period. Males appeared to interact normally with females during cohabitation. However, the typical behavior during this period is for pairs to huddle quietly in one corner of the cage for the majority of the cohabitation period. Thus behavioral suppression would be difficult to detect without more invasive measures.
As noted above, addictive substances often target the same central pathways that modulate social bonding. Although the present study focused on the mesolimbic dopamine system, it should be noted that central opiate systems play a role in social bonding (Panksepp et al., 1997) , and also can be targets of addictive substances (De Vries and Shippenberg, 2002) in part via interactions with dopamine (Koob et al., 1998) . If reciprocal effects between substance abuse and social bonding occur, changes in central functioning associated with responses to drugs could affect pair-bond formation, and vice versa. For example, drugs of abuse can alter signaling pathways associated with D1 receptors (Nestler, 2001) , the activation of which impairs social bonding . Thus, in monogamous voles, drugs of abuse may produce central changes that subsequently make it more difficult to form social bonds. How this might translate to other species is yet to be determined, however, these results suggest that substance abuse could have significant consequences for human bonding.
